PINOT Follow-up Study in End-stage Kidney Disease
Patient Information About Options for Treatment (PINOT) Follow up Study: Answering Important Questions in Home Dialysis and Conservative Care.
1 other identifier
observational
721
2 countries
2
Brief Summary
The primary aims of the Patient INformation about Options for Treatment (PINOT) Follow-up Study are to determine the proportions of patients, identified in the 2009 PINOT cohort that: (i)Made the transition to home dialysis, after an initial start on center-based dialysis. (ii)Commenced dialysis, or a time-limited trial of dialysis within 3 years, after confirmed plans for conservative care. The hypotheses to be tested in the PINOT follow-up study are:
- 1.50% of stage 5 chronic kidney disease patients who plan for home dialysis do not commence home dialysis within 3 years, and instead remain on centre-based haemodialysis; and,
- 2.less than 15% of stage 5 chronic kidney disease patients who plan for conservative care commence dialysis within 3 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2012
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 11, 2013
CompletedFirst Posted
Study publicly available on registry
January 15, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedOctober 26, 2016
October 1, 2016
2.9 years
January 11, 2013
October 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The proportion of patients who make the transition to home dialysis, after an initial start on center-based hemodialysis.
5 years
Secondary Outcomes (1)
The proportion of patients who commence dialysis, or have a time-limited trial of dialysis within 3 and 5 years, after a confirmed plan for conservative care.
5 years
Study Arms (1)
Stage 5 chronic kidney disease
Patients receiving home hemodialysis Patients receiving home peritoneal dialysis Patients receiving center-based hemodialysis Patients who had a pre-emptive kidney transplant Patients who planned for renal conservative care
Interventions
Eligibility Criteria
Adults and children with chronic kidney disease attending renal treatment centres in Australian public hospitals and private practices
You may qualify if:
- Adults and children with end stage kidney disease (eGFR \<15 ml/min) who commenced renal replacement therapy or conservative care in Australia between July and September 2009
You may not qualify if:
- Patients returning to dialysis after a failed transplant,
- Patients with acute renal failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sydneylead
- National Health and Medical Research Council, Australiacollaborator
- Sydney South West Area Health Servicecollaborator
- South West Sydney Local Health Districtcollaborator
- Kidney Health Australiacollaborator
Study Sites (2)
University of Sydney
Sydney, New South Wales, 2006, Australia
University of Oxford
Headington, Oxfordshire, OX38QY, United Kingdom
Related Publications (3)
Morton RL, Howard K, Webster AC, Snelling P. Patient INformation about Options for Treatment (PINOT): a prospective national study of information given to incident CKD Stage 5 patients. Nephrol Dial Transplant. 2011 Apr;26(4):1266-74. doi: 10.1093/ndt/gfq555. Epub 2010 Sep 6.
PMID: 20819955BACKGROUNDMorton RL, Turner RM, Howard K, Snelling P, Webster AC. Patients who plan for conservative care rather than dialysis: a national observational study in Australia. Am J Kidney Dis. 2012 Mar;59(3):419-27. doi: 10.1053/j.ajkd.2011.08.024. Epub 2011 Oct 20.
PMID: 22014401BACKGROUNDMorton RL, Webster AC, McGeechan K, Howard K, Murtagh FEM, Gray NA, Kerr PG, Germain MJ, Snelling P. Conservative Management and End-of-Life Care in an Australian Cohort with ESRD. Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2195-2203. doi: 10.2215/CJN.11861115. Epub 2016 Oct 3.
PMID: 27697783RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rachael L Morton, PhD
University of Sydney
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2013
First Posted
January 15, 2013
Study Start
October 1, 2012
Primary Completion
September 1, 2015
Study Completion
September 1, 2016
Last Updated
October 26, 2016
Record last verified: 2016-10